-+ 0.00%
-+ 0.00%
-+ 0.00%

DMX-200 First 100 Patients Complete Phase 3 Trial Treatment

ASX·10/15/2026 21:53:01

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.